FDA Drug recall D-1508-2014
Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/25 mg, 30 and 90 count bottles, Rx Only, Manufactured for: Daiichi San…
- FDA Drug
- Class II
- terminated
- Published 2014-08-06
On 2014-08-06 the FDA classified a Class II recall of Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/25 mg, 30 and 90 count bottles, Rx Only, Manufactured for: Daiichi San… by Daiichi Sankyo Pharma Development, citing temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1508-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-07-12 |
| Published | 2014-08-06 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Daiichi Sankyo Pharma Development |
| Distribution | US |
Product
Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/25 mg, 30 and 90 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-107-30 and NDC 65597-107-90
Reason
Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.
Identifiers
| code_info | 30 count/Lot #0002108 Exp - 12/31/2016; 90 count/Lot #0002078 Exp - 12/31/2016 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1508-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.